Product containing solriamfetol (medicinal product)
RxNorm 2121751
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2121751 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing solriamfetol (medicinal product).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing solriamfetol (medicinal product)
(Atom ID: 11440993)
INPrescribable
Ingredient (IN):
Solriamfetol
(Atom ID: 12250943)
PTPrescribable
Designated preferred name (PT):
Solriamfetol
(Atom ID: 11441321)
FNPrescribable
Full form of descriptor (FN):
Solriamfetol (substance)
(Atom ID: 11441322)
PTPrescribable
Designated preferred name (PT):
Solriamfetol-containing product
(Atom ID: 11441327)
Patient Education
Solriamfetol
Solriamfetol is used to treat excessive daytime sleepiness caused by narcolepsy (a condition that causes excessive daytime sleepiness). Solriamfetol is also used along with breathing devices or other treatments to prevent excessive daytime sleepiness caused by obstructive sleep apnea/hypopnea syndrome (OSAHS; a sleep disorder in which the patient briefly stops breathing or breathes shallowly many times during sleep and therefore doesn't get enough restful sleep). Solriamfetol is in a class of medications called wakefulness promoting agents. It works by increasing the amounts of certain natural substances in the brain that controls sleep and wakefulness.
[Learn More]
* Please review the disclaimer below.